Jennifer Buell Mi Nk Therapeutics, Inc. (INKT) insider trading activity

Jennifer Buell is Chief Executive Officer of MiNK Therapeutics, Inc.. Currently has a direct ownership of 41,913 shares of INKT, which is worth approximately $535,648. The most recent transaction as insider was on Sep 09, 2025, when has been sold 18,229 shares (Common Stock) at a price of $15.36 per share, resulting in proceeds of $279,997. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 41.9K

0% 3M change

81.95% 12M change

Total Value Held $535,648

Jennifer Buell Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 09 2025	BUY Grant, award, or other acquisition	$279,997 $15.36 p/Share	18,229 Added 30.31%	41,913 Common Stock
Oct 11 2023	SELL Other acquisition or disposition	-	695,750 Reduced 74.98%	232,165 Common Stock
Oct 03 2023	SELL Payment of exercise price or tax liability	$61,100 $0.94 p/Share	65,000 Reduced 6.55%	927,915 Common Stock
Oct 02 2023	SELL Payment of exercise price or tax liability	$60,892 $1.04 p/Share	58,550 Reduced 5.57%	992,915 Common Stock
Sep 29 2023	SELL Payment of exercise price or tax liability	$28,749 $1.15 p/Share	25,000 Reduced 2.32%	1,051,465 Common Stock
Sep 27 2023	BUY Exercise of conversion of derivative security	-	695,750 Added 39.26%	1,076,465 Common Stock
Jan 09 2023	BUY Grant, award, or other acquisition	$399,016 $2.32 p/Share	171,990 Added 31.12%	380,715 Common Stock

Also insider at

AGEN

AGENUS INC Healthcare

PTIXW

Protagenic Therapeutics, Inc.new ETFs

Director

Jennifer Buell

Chief Executive Officer

Lexington, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INKT shares.

Notify only if

Value

Insider Trading

Get notified when an Mi Nk Therapeutics, Inc. insider buys or sells INKT shares.

Notify only if

Operation

Value

Type

News

Receive news related to MiNK Therapeutics, Inc.

Track Activities on INKT

Account